Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interleukin 33 (IL-33) is a cytokine belonging to the IL-1 family that functions both as an intracellular nuclear factor and an extracellular cytokine. It is primarily recognized for its role in immune regulation, tissue homeostasis, and as an "alarmin" released upon cell injury or necrosis. IL-33 activates various immune cells through its receptor ST2, driving type 2 inflammation and influencing metabolic and epigenetic processes. Its activity is tightly controlled by post-release mechanisms such as oxidation and caspase-mediated cleavage.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin 33 (IL-33).